Cargando…

SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes

NADPH oxidase (NOX)-derived oxidative stress is an important factor in renal progression, with NOX4 being the predominant NOX in the kidney. Recently, Src homology 3 (SH3) domain-containing YSC84-like 1 (SH3YL1) was reported to be a regulator of NOX4. In this study, we tested whether the SH3YL1 prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Sang Youb, Han, Seung Hyun, Ghee, Jung Yeon, Cha, Jin Joo, Kang, Young Sun, Cha, Dae Ryong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141384/ https://www.ncbi.nlm.nih.gov/pubmed/37109492 http://dx.doi.org/10.3390/life13040963

Ejemplares similares

Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
por: Han, Sang Youb, et al.
Publicado: (2022)

The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models
por: Han, Sang Youb, et al.
Publicado: (2023)

A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice
por: Min, Hye Sook, et al.
Publicado: (2021)

Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis
por: Cha, Jin Joo, et al.
Publicado: (2020)

Spexin-based galanin receptor 2 agonist improves renal injury in mice with type 2 diabetes
por: Cha, Jin Joo, et al.
Publicado: (2023)

Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway
por: Cha, Jin Joo, et al.
Publicado: (2012)

VSIG4 Induces Epithelial-Mesenchymal Transition of Renal Tubular Cells under High-Glucose Conditions
por: Gong, Eun-Yeung, et al.
Publicado: (2020)

Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice
por: Kim, Jung Eun, et al.
Publicado: (2013)

ACE Gene Polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients
por: Han, Sang Youb, et al.
Publicado: (2000)

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy
por: Han, Sang Youb, et al.
Publicado: (2021)

Effect of IgA Aggregates on Transforming Growth Factor-β1 Production in Human Mesangial Cells and the Intraglomerular Expression of Transforming Growth Factor-β1 in Patients with IgA Nephropathy
por: Han, Sang-Youb, et al.
Publicado: (2005)

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea
por: Cha, Ran-hui, et al.
Publicado: (2017)

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68–78]
por: Cha, Ran-hui, et al.
Publicado: (2018)

Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease
por: Baek, Seon Ha, et al.
Publicado: (2019)

The Role of Visfatin in Diabetic Nephropathy
por: Kang, Young Sun, et al.
Publicado: (2011)

Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy
por: Min, Hye Sook, et al.
Publicado: (2016)

A rare case of perinephric urinoma due to idiopathic retroperitoneal fibrosis
por: Cha, Jin Joo, et al.
Publicado: (2009)

Blood Pressure Control in Patients with Diabetic Kidney Disease
por: Kim, Yaeni, et al.
Publicado: (2022)

Where do we stand on human diabetic nephropathy?
por: Ryong Cha, Dae
Publicado: (2013)

Diabetic kidney disease, revisited: where do we stand?
por: Cha, Dae Ryong
Publicado: (2022)

Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
por: Pak, Eun Seon, et al.
Publicado: (2022)

Serum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study
por: Lee, Sung Woo, et al.
Publicado: (2016)

Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
por: Yun, Jae-Seung, et al.
Publicado: (2021)

Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish
por: Koun, Soonil, et al.
Publicado: (2023)

Long-term study of the association of adipokines and glucose variability with diabetic complications
por: Cha, Jin Joo, et al.
Publicado: (2018)

Phosphodiesterase Inhibitor Improves Renal Tubulointerstitial Hypoxia of the Diabetic Rat Kidney
por: Sun, Hui-Kyoung, et al.
Publicado: (2012)

Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
por: Lee, Ji-Yeon, et al.
Publicado: (2022)

Associations between Renal Hyperfiltration and Serum Alkaline Phosphatase
por: Oh, Se Won, et al.
Publicado: (2015)

Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
por: Ko, Seung-Hyun, et al.
Publicado: (2012)

A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus
por: Kim, Kitae, et al.
Publicado: (2014)

Interleukin-6 signaling in podocyte hypertrophy
por: Cha, Dae Ryong
Publicado: (2016)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Neck circumference predicts renal function decline in overweight women: A community-based prospective cohort study
por: Yoon, Chang-Yun, et al.
Publicado: (2016)

Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet [Volume 33, Issue 1, March 2014, Pages 33–44]
por: Min, Hye Sook, et al.
Publicado: (2015)

Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet
por: Min, Hye Sook, et al.
Publicado: (2014)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

A Case of Rathke’s Cleft Cyst Inflammation Presenting with Diabetes Insipidus
por: Yoon, Jong Woo, et al.
Publicado: (2001)

Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study
por: Kim, Young-Gun, et al.
Publicado: (2016)

Geriatric Nutritional Risk Index as a Prognostic Factor for Renal Progression in Patients with Type 2 Diabetes Mellitus
por: Kim, Eun Jung, et al.
Publicado: (2023)

Soluble α-Klotho as a Novel Biomarker in the Early Stage of Nephropathy in Patients with Type 2 Diabetes
por: Lee, Eun Young, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tg5irqri417eh22ofpcjbkk336